Use of Insulin and Mortality from Breast Cancer among Taiwanese Women with Diabetes

Journal of Diabetes Research

Volumn 2015, Issue , 2015, Pages

  Tseng, Chin Hsiao ^a,b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER RISK; DIABETES MELLITUS; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; TAIWANESE; TREATMENT DURATION; BODY MASS; BREAST TUMOR; COHORT ANALYSIS; COMORBIDITY; MIDDLE AGED; MORTALITY; OVERWEIGHT; RETROSPECTIVE STUDY; RISK FACTOR; SMOKING; TAIWAN; TIME FACTOR;

ADULT; AGED; BODY MASS INDEX; BREAST NEOPLASMS; COHORT STUDIES; COMORBIDITY; DIABETES MELLITUS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MIDDLE AGED; OVERWEIGHT; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING; TAIWAN; TIME FACTORS;

EID: 84932625676     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2015/678756     Document Type: Article

References (35)

1. E. Giovannucci, D. M. Harlan, M. C. Archer et al., "Diabetes and cancer: a consensus report, " Diabetes Care, vol. 33, no. 7, pp. 1674-1685, 2010.
2. C.-H. Tseng, C.-J. Chen, and J. R. Landolph Jr., "Diabetes and cancer: epidemiological, clinical, and experimental perspectives, " Experimental Diabetes Research, vol. 2012, Article ID 101802, 2 pages, 2012.
3. C. H. Tseng, "A review on thiazolidinediones and bladder cancer in human studies, " Journal of Environmental Science and Health C: Environmental Carcinogenesis & Ecotoxicology Reviews, vol. 32, no. 1, pp. 1-45, 2014.
4. C. H. Tseng, K. Y. Lee, and F.H. Tseng, "An updated review on cancer risk associated with incretin mimetics and enhancers, " Journal of Environmental Science and Health C: Environmental Carcinogenesis & Ecotoxicology Reviews, vol. 33, no. 1, pp. 67-124, 2015.
5. H. W. Lin and C. H. Tseng, "A review on the relationship between SGLT2 inhibitors and cancer, " International Journal of Endocrinology, vol. 2014, Article ID 719578, 6 pages, 2014.
6. C.-H. Tseng, "Pioglitazone and bladder cancer: a populationbased study of Taiwanese, " Diabetes Care, vol. 35, no. 2, pp. 278-280, 2012.
7. C.-H. Tseng, C.-K. Chong, and T.-Y. Tai, "Secular trend for mortality from breast cancer and the association between diabetes and breast cancer in Taiwan between 1995 and 2006, " Diabetologia, vol. 52, no. 2, pp. 240-246, 2009.
8. S. Sieri, P. Muti, A. Claudia et al., "Prospective study on the role of glucose metabolism in breast cancer occurrence, " International Journal of Cancer, vol. 130, no. 4, pp. 921-929, 2012.
9. C. H. Tseng, "Diabetes and breast cancer in Taiwanese women: a detectionbias?" European Journal of Clinical Investigation, vol. 44, no. 10, pp. 910-917, 2014.
10. M. E. Del Giudice, I. G. Fantus, S. Ezzat, G. McKeown-Eyssen, D. Page, and P. J. Goodwin, "Insulin and related factors in premenopausal breast cancer risk, " Breast Cancer Research and Treatment, vol. 47, no. 2, pp. 111-120, 1998.
11. G. C. Kabat, M. Kim, B. J. Caan et al., "Repeated measures of serumglucose and insulin in relation to postmenopausal breast cancer, " International Journal of Cancer, vol. 125, no. 11, pp. 2704-2710, 2009.
12. M. L. Irwin, C. Duggan, C.-Y. Wang et al., "Fasting C-peptide levels and death resulting from all causes and breast cancer: the health, eating, activity, and lifestyle study, " Journal of Clinical Oncology, vol. 29, no. 1, pp. 47-53, 2011.
13. K. S. Peairs, B. B. Barone, C. F. Snyder et al., "Diabetesmellitus and breast cancer outcomes: a systematic review and metaanalysis, " Journal of Clinical Oncology, vol. 29, no. 1, pp. 40-46, 2011.
14. P. J. Goodwin, M. Ennis, K. I. Pritchard et al., "Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study, " Journal of Clinical Oncology, vol. 20, no. 1, pp. 42-51, 2002.
15. G. Milazzo, F. Giorgino, G. Damante et al., "Insulin receptor expression and function in human breast cancer cell lines, " Cancer Research, vol. 52, no. 14, pp. 3924-3930, 1992.
16. P. de Meyts, C. T. Christoffersen, B. Ursø et al., "Role of the time factor in signaling specificity: application to mitogenic and metabolic signaling by the insulin and insulin-like growth factor-I receptor tyrosine kinases, " Metabolism, vol. 44, no. 10, supplement 4, pp. 2-11, 1995.
17. A. DeCensi and A. Gennari, "Insulin breast cancer connection: confirmatory data set the stage for better care, " Journal of Clinical Oncology, vol. 29, no. 1, pp. 7-10, 2011.
18. L. G. Hemkens, U. Grouven, R. Bender et al., "Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study, " Diabetologia, vol. 52, no. 9, pp. 1732-1744, 2009.
19. C. J. Currie, C. D. Poole, and E. A. M. Gale, "The influence of glucose-lowering therapies on cancer risk in type 2 diabetes, " Diabetologia, vol. 52, no. 9, pp. 1766-1777, 2009.
20. B. Carstensen, D. R. Witte, and S. Friis, "Cancer occurrence in Danish diabetic patients: duration and insulin effects, " Diabetologia, vol. 55, no. 4, pp. 948-958, 2012.
21. L. L. Lipscombe, H. D. Fischer, P. C. Austin et al., "The association between diabetes and breast cancer stage at diagnosis: a population-based study, " Breast Cancer Research and Treatment, vol. 150, no. 3, pp. 613-620, 2015.
22. L. L. Lipscombe, P. J. Goodwin, B. Zinman, J. R. McLaughlin, and J. E. Hux, "The impact of diabetes on survival following breast cancer, " Breast Cancer Research and Treatment, vol. 109, no. 2, pp. 389-395, 2008.
23. L. L. Lipscombe, P. J. Goodwin, B. Zinman, J. R. McLaughlin, and J. E. Hux, "Increased prevalence of prior breast cancer in women with newly diagnosed diabetes, " Breast Cancer Research and Treatment, vol. 98, no. 3, pp. 303-309, 2006.
24. L. L. Lipscombe, P. J. Goodwin, B. Zinman, J. R. McLaughlin, and J. E. Hux, "Diabetes mellitus and breast cancer: a retrospective population-based cohort study, " Breast Cancer Research and Treatment, vol. 98, no. 3, pp. 349-356, 2006.
25. B. Rosner, A. H. Eliassen, A.T. Toriola et al., "Short-termweight gain and breast cancer risk by hormone receptor classification among pre-and postmenopausal women, " Breast Cancer Research and Treatment, vol. 150, no. 3, pp. 643-653, 2015.
26. F. R. James, S. Wootton, A. Jackson, M. Wiseman, E. R. Copson, and R. I. Cutress, "Obesity in breast cancer-what is the risk factor?" European Journal of Cancer, vol. 51, no. 6, pp. 705-720, 2015.
27. N. Taghizadeh, H. M. Boezen, J. P. Schouten et al., "BMI and lifetime changes in BMI and cancer mortality risk, " PLoS ONE, vol. 10, no. 4, Article ID e0125261, 2015.
28. S.M. George, L. Bernstein, A.W. Smith et al., "Central adiposity after breast cancer diagnosis is related tomortality in theHealth, Eating, Activity, and Lifestyle study, " Breast Cancer Research and Treatment, vol. 146, no. 3, pp. 647-655, 2014.
29. C. Scholz, U. Andergassen, P. Hepp et al., "Obesity as an independent risk factor for decreased survival in node-positive high-risk breast cancer, " Breast Cancer Research and Treatment, vol. 151, no. 3, pp. 569-576, 2015.
30. C. H. Tseng, "Bodymass index and blood pressure in adult type 2 diabetic patients in Taiwan, " Circulation Journal, vol. 71, no. 11, pp. 1749-1754, 2007.
31. S. Chen, C.-M. Chen, Y. Zhou, R.-J. Zhou, K.-D. Yu, and Z.-M. Shao, "Obesity or overweight is associated with worse pathological response to neoadjuvant chemotherapy among Chinese women with breast cancer, " PLoS ONE, vol. 7, no. 7, Article ID e41380, 2012.
32. V. M. Garrisi, A. Tufaro, P. Trerotoli et al., "Body mass index and serum proteomic profile in breast cancer and healthy women: a prospective study, " PLoS ONE, vol. 7, no. 11, Article ID e49631, 2012.
33. C. Villarreal-Garza, R. Shaw-Dulin, F. Lara-Medina et al., "Impact of diabetes and hyperglycemia on survival in advanced breast cancer patients, " Experimental Diabetes Research, vol. 2012, Article ID 732027, 8 pages, 2012.
34. C.-H. Tseng, "Obesity paradox: differential effects on cancer and noncancer mortality in patients with type 2 diabetes mellitus, " Atherosclerosis, vol. 226, no. 1, pp. 186-192, 2013.
35. C.-H. Tseng, "Mortality and causes of death in a national sample of diabetic patients in Taiwan, " Diabetes Care, vol. 27, no. 7, pp. 1605-1609, 2004.